Most cases of Rett syndrome (RTT) are caused by mutations in the methylated DNA-binding protein, MeCP2. Here, we have shown that frequent RTT-causing missense mutations (R106W, R133C, F155S, T158M) located in the methylated DNA-binding domain (MBD) of MeCP2 have profound and diverse effects on its structure, stability, and DNA-binding properties. Fluorescence spectroscopy, which reports on the single tryptophan in the MBD, indicated that this residue is strongly protected from the aqueous environment in the wild type but is more exposed in the R133C and F155S mutations. In the mutant proteins R133C, F155S, and T158M, the thermal stability of the domain was strongly reduced. Thermal stability of the wild-type protein was increased in the presence of unmethylated DNA and was further enhanced by DNA methylation. DNA-induced thermal stability was also seen, but to a lesser extent, in each of the mutant proteins. Circular dichroism (CD) of the MBD revealed differences in the secondary structure of the four mutants. Upon binding to methylated DNA, the wild type showed a subtle but reproducible increase in ␣-helical structure, whereas the F155S and R106W did not acquire secondary structure with DNA. Each of the mutant proteins studied is unique in terms of the properties of the MBD and the structural changes induced by DNA binding. For each mutation, we examined the extent to which the magnitude of these differences correlated with the severity of RTT patient symptoms.A key epigenetic signal in vertebrates is the symmetrical methylation of CpG dinucleotides, which may be passed on to subsequent generations by the action of hemi-methylases on newly replicated DNA (reviewed in Ref. 1). Screening for proteins that bind preferentially to methylated CpGs has revealed a family of methylated DNA-binding proteins, the founding member of which is the conserved and highly basic 52-kDa methylated DNA-binding protein 2, MeCP2 2 (reviewed in Ref.2). The portion of MeCP2 responsible for binding methylated DNA is known as the MBD (methylated DNA-binding domain), which extends from residues ϳ75 to ϳ164 (3). NMR and x-ray studies (4, 5) have shown the MBD to be ϳ60% structured, with segments of ␣-helix, -strand, and -turn forming a wedge-shaped structure (Fig. 1b). In contrast, the N-and C-terminal portions of MeCP2 are predicted to be largely unstructured (6). Signals encoded in methylated CpGs frequently lead to transcriptional repression, which appears to be a prominent consequence of MeCP2 binding (7). One model of the mechanism that leads from MeCP2 binding to transcriptional repression involves the recruitment of Sin 3A and histone deacetylase followed by local histone modification (8, 9). However, recent evidence suggests that MeCP2 locations in chromatin are not confined to sites of methylated DNA and that MeCP2 occupancy does not necessarily lead to transcriptional repression (10). Moreover, it is now clear that MeCP2 has a wide range of potential functions (reviewed in Refs. 11 and 12), including an involvement in RNA proce...